Manufacturer of Controlled Substances; Notice of Registration, 28074 [E7-9634]
Download as PDF
<![CDATA[
28074
Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices
Dated: May 10, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9606 Filed 5–17–07; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
By Notice dated November 2, 2006,
and published in the Federal Register
on November 8, 2006, (71 FR 65544),
Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
II:
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
pwalker on PROD1PC71 with NOTICES
By Notice dated December 14, 2006,
and published in the Federal Register
on December 22, 2006, (71 FR 77065–
77066), Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of 14–
Hydroxymorphinone (9654), a basic
class of controlled substance listed in
schedule II.
The company plans to manufacture
the listed controlled substances in bulk
as an intermediate for use in the
production of another controlled
substance.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Johnson
Matthey Inc to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9617 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
17:06 May 17, 2007
Jkt 211001
Drug
Schedule
Nabilone (7379) ............................
Noroxymorphone (9668) ..............
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sales to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Johnson Matthey Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9629 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated December 14, 2006,
and published in the Federal Register
on December 22, 2006, (71 FR 77065),
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Remifentanil (9739), a
basic class of controlled substance listed
in schedule II.
The company plans on producing this
item for sale to its customers, who are
final dosage manufacturers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Johnson Matthey Inc to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Johnson
Matthey Inc to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: May 9, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–9634 Filed 5–17–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated December 14, 2006,
and published in the Federal Register
on December 22, 2006, (71 FR 77065–
77066), Johnson Matthey Inc., Custom
Pharmaceuticals Department, 2003
Nolte Drive, West Deptford, New Jersey
08066, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of 14–
Hydroxymorphinone (9654), a basic
class of controlled substance listed in
schedule II.
The company plans to manufacture
the listed controlled substances in bulk
as an intermediate for use in the
production of another controlled
substance.
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Page 28074]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9634]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated December 14, 2006, and published in the Federal
Register on December 22, 2006, (71 FR 77065), Johnson Matthey Inc.,
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New
Jersey 08066, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of
Remifentanil (9739), a basic class of controlled substance listed in
schedule II.
The company plans on producing this item for sale to its customers,
who are final dosage manufacturers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Johnson Matthey Inc to manufacture the listed basic class of controlled
substance is consistent with the public interest at this time. DEA has
investigated Johnson Matthey Inc to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with State and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the
above named company is granted registration as a bulk manufacturer of
the basic class of controlled substance listed.
Dated: May 9, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-9634 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P
